BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 7386528)

  • 21. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles.
    Branch CM; Collins PO; Collins WP
    J Steroid Biochem; 1982 Feb; 16(2):345-7. PubMed ID: 7078170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotrophin and steroid interrelationships during the normal menstrual cycle.
    Bell ET; Christie DW
    Steroidologia; 1970; 1(3):152-74. PubMed ID: 4940024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.
    Wright K; Collins DC; Preedy JR
    Steroids; 1979 Oct; 34(4):445-57. PubMed ID: 229588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal patterns and interactions in the normal menstrual cycle.
    Rankin JS
    Clin Obstet Gynecol; 1969 Sep; 12(3):741-54. PubMed ID: 4899781
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research.
    O'Connor KA; Brindle E; Holman DJ; Klein NA; Soules MR; Campbell KL; Kohen F; Munro CJ; Shofer JB; Lasley BL; Wood JW
    Clin Chem; 2003 Jul; 49(7):1139-48. PubMed ID: 12816911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a rapid method for determination of total urinary estrogens in morning samples from normally menstruating women.
    Fleetwood L; Shu-rong Z; Eneroth P; Landgren BM
    Contraception; 1983 Apr; 27(4):329-38. PubMed ID: 6851563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The direct radioimmunoassay of oestrogen glucuronides in human female urine.
    Baker TS; Jennison KM; Kellie AE
    Biochem J; 1979 Feb; 177(2):729-38. PubMed ID: 435263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Composite microassays of plasma progesterone, 17alpha-OH-progestrerone, estrone, 17beta-estradiol and estriol in normal adult women. I. Assay methods and steroid patterns in normal menstrual cycle (author's transl)].
    Suginami H
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):908-23. PubMed ID: 1241848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
    Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
    Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. 1. Dynamic changes during the periovulatory period.
    Aedo AR; Landgren BM; Diczfalusy E
    Contraception; 1981 Feb; 23(2):107-24. PubMed ID: 7238039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens.
    Larsson-Cohn U; Johansson ED; Wide L; Gemzell C
    Acta Endocrinol (Copenh); 1970 Feb; 63(2):216-24. PubMed ID: 5468622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validations of time-resolved fluoroimmunoassays for urinary estrone 3-glucuronide and pregnanediol 3-glucuronide.
    Kesner JS; Knecht EA; Krieg EF; Barnard G; Mikola HJ; Kohen F; Gani MM; Coley J
    Steroids; 1994 Mar; 59(3):205-11. PubMed ID: 8048153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
    Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods of monitoring menstrual function in field studies: efficacy of methods.
    Kesner JS; Wright DM; Schrader SM; Chin NW; Krieg EF
    Reprod Toxicol; 1992; 6(5):385-400. PubMed ID: 1463919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone excretion patterns during and ater the long-term administration of oral contraceptives.
    Loraine JA; Bell ET; Harkness RA; Mears E; Jackson MC
    Acta Endocrinol (Copenh); 1965 Sep; 50(1):15-24. PubMed ID: 5897062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of luteinizing hormone, pregnanediol-3-glucuronide, and estriol-16-glucuronide in urine of infertile women with endometriosis.
    Cheesman KL; Ben-Nun ; Chatterton RT; Cohen MR
    Fertil Steril; 1982 Nov; 38(5):542-8. PubMed ID: 7128839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovulatory menstrual cycles with abnormal urinary steroid patterns.
    Loraine JA; Bell ET
    J Obstet Gynaecol Br Commonw; 1968 Jan; 75(1):71-7. PubMed ID: 5635247
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
    Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
    Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.